Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
- 4 May 2020
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 19 (7), 102567
- https://doi.org/10.1016/j.autrev.2020.102567
Abstract
No abstract availableThis publication has 180 references indexed in Scilit:
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirinScientific Reports, 2013
- Sensing of RNA Viruses: a Review of Innate Immune Receptors Involved in Recognizing RNA Virus InvasionJournal of Virology, 2012
- Plasmacytoid dendritic cells control T-cell response to chronic viral infectionProceedings of the National Academy of Sciences of the United States of America, 2012
- Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63Journal of Virology, 2010
- Coronaviruses post-SARS: update on replication and pathogenesisNature Reviews Microbiology, 2009
- The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNAImmunity, 2009
- Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsetsThe Journal of Experimental Medicine, 2008
- Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entryProceedings of the National Academy of Sciences of the United States of America, 2008
- Induction of Apoptosis by the Severe Acute Respiratory Syndrome Coronavirus 7a Protein Is Dependent on Its Interaction with the Bcl-X L ProteinJournal of Virology, 2007
- Interleukin-10 determines viral clearance or persistence in vivoNature Medicine, 2006